Factors that could cause actual results to differ materially from those implied by these forward-looking statements include, but are not limited to: the final amount of charges resulting from the North American asset realignment and our ability to realize anticipated savings and operational benefits from the asset realignment; our ability to achieve the strategic and other objectives relating to the acquisition of Spartech Corporation, including any expected synergies; our ability to successfully integrate Spartech and achieve the expected results of the acquisition, including, without limitation, the acquisition being accretive at expected levels and within the expected timeframe; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the financial condition of our customers, including the ability of customers (especially those that may be highly leveraged and those with inadequate liquidity) to maintain their credit availability; the speed and extent of an economic recovery, including the recovery of the housing market; our ability to achieve new business gains; the effect on foreign operations of currency fluctuations, tariffs, and other political, economic and regulatory risks; changes in polymer consumption growth rates where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to working capital reductions, cost reductions, and employee productivity goals; an inability to raise or sustain prices for products or services; an inability to maintain appropriate relations with unions and employees; the inability to achieve expected results from our acquisition activities; our ability to continue to pay cash dividends; the amount and timing of repurchases of our common shares, if any; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.

Together, we will benefit from the combined ingenuity, passion and expertise of two global leaders in color design, additive technologies and sustainable solutions," said color and additive masterbatch business, including, without limitation, the acquisition being accretive; disruptions, uncertainty or volatility in the credit markets that could adversely impact the availability of credit already arranged and the availability and cost of credit in the future; the effect on foreign operations of currency fluctuations, tariffs and other political, economic and regulatory risks; changes in polymer consumption growth rates and laws and regulations regarding plastics in jurisdictions where we conduct business; changes in global industry capacity or in the rate at which anticipated changes in industry capacity come online; fluctuations in raw material prices, quality and supply, and in energy prices and supply; production outages or material costs associated with scheduled or unscheduled maintenance programs; unanticipated developments that could occur with respect to contingencies such as litigation and environmental matters; an inability to raise or sustain prices for products or services; an ability to achieve or delays in achieving or achievement of less than the anticipated financial benefit from initiatives related to acquisition and integration, working capital reductions, costs reductions and employee productivity goals; information systems failures and cyberattacks; and other factors affecting our business beyond our control, including, without limitation, changes in the general economy, changes in interest rates and changes in the rate of inflation.

SWITCHING FROM STEEL TO NYLON CREATES MULTIPLE BENEFITS CASE STUDY: BERGAMID™ NYLON FORMULATIONS Challe nge Accepted. THE SOLUTION Avient recommended Bergamid™ B70 G30H black TM-X PA 6 resin with 30 percent glass fiber reinforcement for its excellent mechanical properties and cost benefits. THE IMPACT By replacing traditional fabricated bent steel plate with injection-molded Bergamid PA 6 resin, HellermannTyton was able to duplicate key performance attributes while gaining new benefits in the areas of cost savings, design freedom and weight reduction.

Retirement Benefits. Other Benefits. Other Benefits.

Retirement Benefits. Other Benefits. In general, other benefits include a nominal benefit allowance (provided to Mr.

Retirement Benefits. Other Benefits. In general, these benefits include a nominal benefit allowance (provided to Messrs.

INCREASED RECYCLE CONTENT Benefits of using rePrize include: • Increased product target IV • Improved melt flow consistency • Increased recycle content • Reduced brittleness • Reduced rejects and scrap • Improved low temperature performance rePrize can be combined with other liquid additives and can be used to optimize sheet manufacturing processes and product quality, whilst allowing for increased levels of recycle, contributing towards improved sustainability and reduced costs. FEATURE BENEFIT • Liquid technology • More accurate dose control • Less variation in melt flow and product IV • Can be coupled to an on-line rheometer • Shorter transition times • Does not require pre-drying • Less dust • Higher IV in melt phase • Improved uniformity when replacing virgin PET in PCR sheet • Eliminate/reduce solid phase polymerization (rPET) • Increased use of post consumer flake or re-grind (Sheet) • Reduced brittleness, less breakages and scrap • More consistent melt flow IMPACT • Reduced cost • Higher productivity • Cleaner working environment PROCESS HIGHLIGHTS IMPACT • Higher productivity • Reduced cost • Cleaner working environment • New product designs and applications • Improved shelf appeal PET SHEET PROCESS BENEFITS • Increases final IV • Less variation in product IV • More consistent melt flow • Increased use of flake or regrind • Shorter transition times • Reduced scrap • Reduced dust PRODUCT BENEFITS • Improved impact strength • Improved low temperature performance • Reduced brittleness • Improved aesthetics Information and photographs supplied by Sunwell Global Ltd IMPACT • Higher productivity • Reduced cost • Improved sustainability IMPACT • Lighter weight, higher strength • Reduced cost • Properties comparable to PS packaging • Recyclable PET MONO/MULTI LAYERED SHEET XPET FOAM SHEET ROUND DIE PROCESS BENEFITS • Improved melt flow consistency • Improved IV consistency • Increased recycle content • Reduced rejects and scrap PRODUCT BENEFITS • Increased product strength • Improved low temperature performance • Reduced brittleness PROCESS BENEFITS • Increase final IV • Increased use of regrind • Impossible to start up without it • Faster product changeover • Easier to cut PRODUCT BENEFITS • Increased strength • Lighter weight • Good sealing ColorMatrix™ rePrize is a PET compatible formulated liquid dispersion, designed to increase the polymer chain length via reactive extrusion.

Take a closer look at the benefits of continuous fiber reinforced thermoplastic composites.  Learn more about advanced polymer technologies that enhance EV battery design and performance to enable benefits such as extended vehicle range, lightweighting and sustainability.

Benefit Plans. • Review and approve, or recommend to the Board the approval of, the structure of the Company’s retirement plans, and other benefit plans that are compensatory in nature. Committee Meetings and Action • A majority of the Committee members will be a quorum for the transaction of business. • The action of a majority of those present at a meeting at which a quorum is present will be the act of the Committee. • Any action that may be taken at a meeting of the Committee may be taken by written consent so long as the written consent is unanimously approved and filed with the Corporate Secretary. • The Company’s Chief Human Resources Officer will be the management liaison to the Committee with respect to matters concerning compensation and benefits. • The Committee may invite such members of management to its meetings as it deems appropriate. However, the Committee shall meet regularly without such members present, and in all cases the Chief Executive Officer and any other such officers shall not be present at those portions of meetings at which their individual compensation or performance is discussed or determined. • The Committee may appoint subcommittees from time to time as needed, each of which will have the specific duties and responsibilities delegated to it by the Committee. • The Committee may delegate its authority under this Charter relating to employees other than executive officers and non-employee directors, to the extent it deems appropriate and consistent with law and customary practice and may otherwise fully delegate authority relating to matters it deems to be ministerial. • The Committee may delegate its authority under this Charter relating to employee benefit plans in which executive officers participate if such employee benefit plans are broad-based, to the extent it deems appropriate and consistent with law and customary practice. • The Corporate Secretary or designee will be responsible for keeping minutes of the Committee meetings. • The Committee will meet at least four times a year and at such other times as may be requested by the Committee Chair. • The Committee will annually review its charter and recommend any changes to the Governance and Corporate Responsibility Committee.

The company noted that GAAP EPS includes special items of $0.29 (Attachment 3) primarily associated with one-time tax benefits of $0.35, which was partially offset by acquisition-related and restructuring costs. Patterson said, “As the COVID-19 vaccine brings hope for a recovery from the pandemic, we anticipate our businesses will continue to benefit from new product development requiring sustainable solutions as well as demand for consumer and healthcare applications. We will also uniquely benefit from the Clariant Masterbatch acquisition and related synergy capture, which is well ahead of schedule.”